Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SCHAUMBURG, Ill., Oct. 29, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Leucovorin Calcium for Injection, a folic acid derivative, and an adjuvant...
-
SCHAUMBURG, Ill., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that it will release financial results for the third quarter of 2012 pre-market on...
-
SCHAUMBURG, Ill., Oct. 3, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP,...
-
SCHAUMBURG, Ill., Sept. 28, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 5...
-
SCHAUMBURG, Ill., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Ondansetron Injection, USP, an antiemetic, in two latex-free vial...
-
SCHAUMBURG, Ill., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Oxaliplatin for Injection, USP, the generic form of the chemotherapy drug,...
-
Revenue Growth Driven by Products Launched in the Last Twelve Months Company Revises Guidance for 2012 SCHAUMBURG, Ill., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc....
-
SCHAUMBURG, Ill., July 26, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that it will release financial results for the second quarter of 2012 pre-market on...
-
SCHAUMBURG, Ill., July 24, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Oxacillin for Injection, USP, in three latex-free, preservative-free vial...
-
SCHAUMBURG, Ill., May 18, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Atracurium Besylate Injection, USP, the generic form of the neuromuscular...